Song, Y., Cai, Q., Guo, Y., Liu, H., Wang, M., Huang, W., Zhang, M., Liu, Y., Li, L., Shuang, Y., Li, Z., Niu, C., Chen, L., Chen, J., Xie, Y. (2025). Phase 1 study of MK-1045, a novel CD19xCD3 T-cell engager, in participants with relapsed or refractory diffuse large B-cell lymphoma. Blood. https://doi.org/10.1182/blood-2025-3740